Search results
FDA Approves Biosimilars for Macular Degeneration Treatment
Healthline via AOL· 2 days agoThe FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work...
Blood test to detect colon cancer could move a step closer to FDA approval in the US
CNN via Yahoo News· 22 hours agoGuardant Health’s Shield tests could be the first approved blood screening test for colorectal...
Can You Get Ozempic at Costco? See How to Save on Weight Loss Drugs
Motley Fool via Yahoo Finance· 8 hours agoBut GLP-1 drugs are not cheap. Without insurance, the exact price can range from $950-$1,600 per...
Ovarian cancer drug developer's stock cut in half after it files for FDA approval - Boston Business...
The Business Journals· 4 hours agoNeedham cancer drug developer Verastem Oncology saw its stock plunge over 60% Friday morning as of...
Guardant Health Jumps — As Exact Sciences Slumps — On A Key FDA Move For Blood Tests
Investor's Business Daily· 4 hours agoGuardant Health stock jumped Friday after a Food and Drug Administration panel recommended the...
FDA approves CorTec’s implant system for stroke rehabilitation study
Medical Device Network via Yahoo Finance· 11 hours agoPatient enrolment and the inaugural implantation of the neural interfacing system are scheduled for...
FDA upgrades safety alert for Hologic's breast cancer marking implant, after 71 reported injuries
FierceBiotech· 5 hours agoThe FDA is upgrading its safety warnings related to complications from Hologic’s implantable marker...
Heuron’s AI solution for stroke triage receives FDA clearance
Medical Device Network via Yahoo Finance· 7 hours agoOur commitment extends beyond this achievement as we endeavour to expand our portfolio of FDA-...
Guardant Health Stock Jumps 12%
Barrons.com· 3 hours agoThe FDA is expected to decide whether or not to approve the blood test, Shield, later this year.Read the full article
FDA approves belimumab autoinjector for pediatric systemic lupus erythematosus
Medical Xpress· 1 day agoThe U.S. Food and Drug Administration has approved GlaxoSmithKline's 200-mg subcutaneous route of...
